Formations of, Acquisitions by, and Mergers of Bank Holding Companies, 941 [2013-00046]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 4 / Monday, January 7, 2013 / Notices
FEDERAL RESERVE SYSTEM
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
Office of the Secretary
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications will also be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than January 31,
2013.
A. Federal Reserve Bank of St. Louis
(Yvonne Sparks, Community
Development Officer) P.O. Box 442, St.
Louis, Missouri 63166–2034:
1. Jacksonville Bancorp, Inc.,
Jacksonville, Illinois; to become a bank
holding company through the
termination of the election by
Jacksonville Savings Bank, Jacksonville,
Illinois to be treated as a savings
association.
wreier-aviles on DSK7SPTVN1PROD with
Dated: Board of Governors of the Federal
Reserve System, January 2, 2013.
Michael J. Lewandowski,
Assistant Secretary of the Board.
[FR Doc. 2013–00046 Filed 1–4–13; 8:45 am]
BILLING CODE 6210–01–P
VerDate Mar<15>2010
15:16 Jan 04, 2013
Jkt 229001
Findings of Research Misconduct
Office of the Secretary, HHS
Notice.
AGENCY:
ACTION:
Notice is hereby given that
the Office of Research Integrity (ORI)
has taken final action in the following
case:
Paul J. Muchowski, Ph.D., The J.
David Gladstone Institutes: Based on the
report of an investigation conducted by
The J. David Gladstone Institutes
(Gladstone) and additional analysis
conducted by ORI in its oversight
review, ORI found that Dr. Paul J.
Muchowski, former Senior Investigator,
Gladstone Institute of Neurological
Disease, Gladstone, engaged in research
misconduct in research supported by
National Institute of Neurological
Diseases and Stroke (NINDS), National
Institutes of Health (NIH), grant R01
NS054753–06A1.
ORI found that the Respondent
engaged in research misconduct by
falsifying and fabricating data that was
included in one (1) funded NIH grant
R01 NS054753–06A1 and two (2)
submitted NIH grant applications R01
NS054753–06 and R01 NS047237–06.
Specifically, ORI finds that the
Respondent knowingly and
intentionally:
• Falsely reported research
experiments when the results did not
exist at the time the grant applications
were submitted. Specifically:
fl in Figures 19–21 and related text
of grant application R01 NS047237–06,
the Respondent claimed he had
successfully transduced human
neuroblastoma SH–SY5Y cells
expressing a-synuclein (aSyn) with
lentiviruses containing small hairpin
RNAs (shRNAs) that targeted Cog6,
Stx7, Vps52, or Vps33a. The
Respondent reported lentiviral
expressed Cog6 significantly
exacerbated a-Syn toxicity in SH–SY5Y
cells, when only plasmid shRNAs were
generated and utilized at the time the
grant application was submitted.
fl in Figure 5 and the accompanying
text of grant R01 NS054753–06A1, the
Respondent described the insertion of
toxic and inert mutant huntingtin (htt)
fragments into maltose binding proteinHtt-Cerulean constructs with a
nonpathogenic (25Q) or pathogenic
(46Q) polyQ repeat, with and without
Cerulean. The modified proteins were
claimed to have been purified, when the
constructs had not been made at the
time the grant was submitted.
SUMMARY:
PO 00000
Frm 00014
Fmt 4703
Sfmt 9990
941
fl in Figures 5 and 6 and the
accompanying text of grant R01
NS054753–06A1, the Respondent
claimed to have cloned toxic and inert
mutant htt fragments into lentiviral
constructs and generated lentiviruses,
when the constructs were not made.
fl in Figure 6 and related text in
grant R01 NS054753–06A1, the
Respondent claimed to have tested
immunoblots of lysates from primary
neurons with an antibody against
mutant htt, which demonstrated that
levels of htt expression in transduced
cells were roughly equivalent to levels
in normal neurons, when the
experiment was not conducted.
• Falsified Figure 3 of grant
application R01 NS054753–06 by
labeling the Western blot images for the
expression of mutant htt in lentiviraltransduced primary neurons as ‘Cortex’
(left panel) and ‘Striatum’ (right panel),
when the results were actually from the
microglial cell lines N9 and BV2,
respectively.
Dr. Muchowski has entered into a
Voluntary Settlement Agreement and
has voluntarily agreed for a period of
two (2) years, beginning on December
10, 2012:
(1) To have his research supervised;
Respondent agreed that prior to the
submission of an application for PHS
support for a research project on which
his participation is proposed and prior
to his participation in any capacity on
PHS-supported research, Respondent
shall ensure that a plan for supervision
of his duties is submitted to ORI for
approval; the supervision plan must be
designed to ensure the scientific
integrity of his research contribution; he
agreed that he shall not participate in
any PHS-supported research until such
a supervision plan is submitted to and
approved by ORI; Respondent agreed to
maintain responsibility for compliance
with the agreed upon supervision plan;
and
(2) to exclude himself voluntarily
from serving in any advisory capacity to
PHS including, but not limited to,
service on any PHS advisory committee,
board, and/or peer review committee, or
as a consultant.
FOR FURTHER INFORMATION CONTACT:
Director, Office of Research Integrity,
1101 Wootton Parkway, Suite 750,
Rockville, MD 20852, (240) 453–8200.
David E. Wright,
Director, Office of Research Integrity.
[FR Doc. 2013–00010 Filed 1–4–13; 8:45 am]
BILLING CODE 4150–31–P
E:\FR\FM\07JAN1.SGM
07JAN1
]]>Agencies
[Federal Register Volume 78, Number 4 (Monday, January 7, 2013)]
[Notices]
[Page 941]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-00046]
[[Page 941]]
=======================================================================
-----------------------------------------------------------------------
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and Mergers of Bank Holding
Companies
The companies listed in this notice have applied to the Board for
approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C.
1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other
applicable statutes and regulations to become a bank holding company
and/or to acquire the assets or the ownership of, control of, or the
power to vote shares of a bank or bank holding company and all of the
banks and nonbanking companies owned by the bank holding company,
including the companies listed below.
The applications listed below, as well as other related filings
required by the Board, are available for immediate inspection at the
Federal Reserve Bank indicated. The applications will also be available
for inspection at the offices of the Board of Governors. Interested
persons may express their views in writing on the standards enumerated
in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the
acquisition of a nonbanking company, the review also includes whether
the acquisition of the nonbanking company complies with the standards
in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted,
nonbanking activities will be conducted throughout the United States.
Unless otherwise noted, comments regarding each of these
applications must be received at the Reserve Bank indicated or the
offices of the Board of Governors not later than January 31, 2013.
A. Federal Reserve Bank of St. Louis (Yvonne Sparks, Community
Development Officer) P.O. Box 442, St. Louis, Missouri 63166-2034:
1. Jacksonville Bancorp, Inc., Jacksonville, Illinois; to become a
bank holding company through the termination of the election by
Jacksonville Savings Bank, Jacksonville, Illinois to be treated as a
savings association.
Dated: Board of Governors of the Federal Reserve System, January
2, 2013.
Michael J. Lewandowski,
Assistant Secretary of the Board.
[FR Doc. 2013-00046 Filed 1-4-13; 8:45 am]
BILLING CODE 6210-01-P
